Literature DB >> 11430722

Microcephalus, medulloblastoma and excessive toxicity from chemotherapy: an unusual presentation of Fanconi anaemia.

E Ruud1, F Wesenberg.   

Abstract

UNLABELLED: Fanconi anaemia is a genetically and phenotypically heterogeneous disorder with different forms of clinical presentation. In this case the patient had suffered from microcephalus and delayed motor development from birth, but extensive investigation did not disclose any aetiology. At 3.5 y she developed a cerebellar medulloblastoma which was treated with surgery and chemotherapy. Following chemotherapy with alkylating agents she suffered from severe bone marrow aplasia which caused life-threatening infections, feeding problems and impaired kidney function. Fanconi anaemia was suspected, but it took 2 mo before the chromosome fragility test came out positive. From the moment diagnosis of Fanconi anaemia was made, no further active treatment was given. The patient's condition improved for some time, but she relapsed and died exactly 1 y after the first diagnosis of brain tumour.
CONCLUSION: Fanconi anaemia must always be suspected in patients who experience excessive toxicity from chemotherapy regardless of the type of malignancy and congenital malformations.

Entities:  

Mesh:

Year:  2001        PMID: 11430722

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  6 in total

1.  Hepatic Sinusoidal Obstruction Syndrome in a child after chemotherapy for medulloblastoma.

Authors:  M Kashif Ishaqi; A Jamil; M Khanani; M Baroudi; Omar Trad; M El-Hayek; Eric Bouffet
Journal:  J Neurooncol       Date:  2009-08-23       Impact factor: 4.130

2.  Fanconi anemia and biallelic BRCA2 mutation diagnosed in a young child with an embryonal CNS tumor.

Authors:  Mariko D Dewire; David W Ellison; Zoltan Patay; Peter J McKinnon; Robert P Sanders; Amar Gajjar
Journal:  Pediatr Blood Cancer       Date:  2009-12       Impact factor: 3.167

3.  Characterization of medulloblastoma in Fanconi Anemia: a novel mutation in the BRCA2 gene and SHH molecular subgroup.

Authors:  Evelina Miele; Angela Mastronuzzi; Agnese Po; Andrea Carai; Vincenzo Alfano; Annalisa Serra; Giovanna Stefania Colafati; Luisa Strocchio; Manila Antonelli; Francesca Romana Buttarelli; Massimo Zani; Sergio Ferraro; Amelia Buffone; Alessandra Vacca; Isabella Screpanti; Felice Giangaspero; Giuseppe Giannini; Franco Locatelli; Elisabetta Ferretti
Journal:  Biomark Res       Date:  2015-06-06

Review 4.  Fanconi anemia and dyskeratosis congenita/telomere biology disorders: Two inherited bone marrow failure syndromes with genomic instability.

Authors:  Moisés Ó Fiesco-Roa; Benilde García-de Teresa; Paula Leal-Anaya; Renée van 't Hek; Talia Wegman-Ostrosky; Sara Frías; Alfredo Rodríguez
Journal:  Front Oncol       Date:  2022-08-25       Impact factor: 5.738

5.  Disseminated Medulloblastoma in a Child with Germline BRCA2 6174delT Mutation and without Fanconi Anemia.

Authors:  Jingying Xu; Ashley Sloane Margol; Anju Shukla; Xiuhai Ren; Jonathan L Finlay; Mark D Krieger; Floyd H Gilles; Fergus J Couch; Meraj Aziz; Eric T Fung; Shahab Asgharzadeh; Michael T Barrett; Anat Erdreich-Epstein
Journal:  Front Oncol       Date:  2015-08-27       Impact factor: 6.244

Review 6.  Genetic syndromes predisposing to pediatric brain tumors.

Authors:  Sameer Farouk Sait; Michael F Walsh; Matthias A Karajannis
Journal:  Neurooncol Pract       Date:  2021-02-13
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.